fbpx
DealsHealth

Reuters exclusively reportes EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccines

Reuters exclusively reported that the European Union is negotiating advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna, Sanofi and Johnson & Johnson as well as biotech firms BioNtech and CureVac. The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential COVID-19 vaccine, in principle available to all 27 EU nations. The multiple talks confirm the bloc’s more assertive stance on procuring potential COVID-19 shots and drugs after early U.S. moves in securing promising treatments and vaccines.

Article Tags
Topics of Interest: DealsHealth
Type: Reuters Best
Sectors: Equities
Regions: Europe
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text